Suchergebnisse - "Specchia, Giorgina"

PubPharm (544)

51

Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation

enthalten in: Supportive care in cancer | 2021

von Di Renzo, N. | Musso, M. | Scimè, R. | +19

52

Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation

enthalten in: Supportive care in cancer | 2021

von Di Renzo, N. | Musso, M. | Scimè, R. | +19

53

Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation

enthalten in: Supportive care in cancer | 2021

von Di Renzo, N. | Musso, M. | Scimè, R. | +19

54

Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia

enthalten in: Scientific reports | 2021

von Minervini, C. | Cumbo, C. | Redavid, I. | +13

55

Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?

enthalten in: Cancers | 2021

von Tarantini, F. | Cumbo, C. | Anelli, L. | +4

56

Hypereosinophilia with a pinch of salt and pepper

enthalten in: EJHaem | 2021

von Vitucci, A. | Tarantini, F. | Ingravallo, G. | +3

57

Bosutinib in the real-life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine-kinase inhibitors

enthalten in: Hematological oncology | 2021

von Latagliata, R. | Attolico, I. | Trawinska, M. | +26

58

Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi

enthalten in: Annals of hematology | 2021

von Santoro, A. | Mazza, R. | Spina, M. | +24

59

Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi

enthalten in: Annals of hematology | 2021

von Santoro, A. | Mazza, R. | Spina, M. | +24

60

Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi

enthalten in: Annals of hematology | 2021

von Santoro, A. | Mazza, R. | Spina, M. | +24